Impact of thiopurine discontinuation at anti‐tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study-Reference-Cited by-同舟云学术

Impact of thiopurine discontinuation at anti‐tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study

Published:2022-01-25 Issue:9 Volume:55 Page:1128-1138
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Thomsen Sandra Bohn¹^ORCID,Ungaro Ryan C.²^ORCID,Allin Kristine H.¹^ORCID,Elmahdi Rahma¹^ORCID,Poulsen Gry³^ORCID,Andersson Mikael³^ORCID,Colombel Jean‐Frederic²^ORCID,Jess Tine¹⁴^ORCID

Affiliation:

1. Department of Clinical Medicine Center for Molecular Prediction of Inflammatory Bowel Disease Aalborg University Copenhagen Denmark

2. Division of Gastroenterology Icahn School of Medicine at Mount Sinai New York City New York USA

3. Department of Epidemiology Research Statens Serum Institut Copenhagen Denmark

4. Department of Gastroenterology and Hepatology Aalborg University Hospital Denmark

Funder

Danmarks Grundforskningsfond

Foundation for the National Institutes of Health

Torben og Alice Frimodts Fond

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16777

Reference43 articles.

1. Crohn's disease

2. Ulcerative colitis

3. Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

4. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

5. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis;Lawson MM;Cochrane Database Syst Rev,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulator Withdrawal From Anti-TNF Therapy Needs a Careful Patient Selection;Clinical Gastroenterology and Hepatology;2023-02

2. Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients;Therapeutic Drug Monitoring;2022-12

3. Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease;Digestion;2022-11-30

4. Letter: is blindly stopping thiopurines without confirming adequate anti‐TNF concentrations shortsighted?;Alimentary Pharmacology & Therapeutics;2022-03-22

5. Editorial: anti‐TNF combination therapy for inflammatory bowel disease–one size does not fit all;Alimentary Pharmacology & Therapeutics;2022-03